Literature DB >> 11237823

Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects.

L A Pinto1, V Blazevic, S A Anderson, D J Venzon, C M Trubey, T Rowe, J M Katz, D Liewehr, M J Dolan, G M Shearer.   

Abstract

Influenza virus stimulation of leukocytes induces factors that suppress human immunodeficiency virus (HIV). The effect of influenza vaccination on influenza-induced anti-HIV activity was investigated. Influenza vaccine was administered to 25 control subjects and 20 HIV-infected patients. Antiviral activity, cytokine production, and influenza antibodies were assessed before and 2 and 6 weeks after vaccination. Immunization induced a statistically significant increase in antiviral activity in control subjects but not in HIV patients, although the number of patients who generated this activity increased. Pre- and postvaccination levels of anti-HIV activity were significantly lower in HIV patients. Vaccination of control subjects and HIV patients induced increases in production of interleukin-2 and interferon (IFN)-gamma, but not of IFN-alpha. Virus load and CD4 cell counts were not significantly altered. This study demonstrates impairment of antiviral activity in HIV patients, in addition to deficiencies in antibody responses and cytokine production. In summary, influenza vaccination can induce an increase in multiple immunologic components that remained impaired in HIV patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237823     DOI: 10.1086/319277

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  In vitro suppression of human immunodeficiency virus type 1 replication by measles virus.

Authors:  Mayra García; Xiao-Fang Yu; Diane E Griffin; William J Moss
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine.

Authors:  Yu Bin Seo; Jacob Lee; Joon Young Song; Hee Jung Choi; Hee Jin Cheong; Woo Joo Kim
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

3.  Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens.

Authors:  Sang-Moo Kang; Lizheng Guo; Qizhi Yao; Ioanna Skountzou; Richard W Compans
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 4.  Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective.

Authors:  Charles R Beck; Bruce C McKenzie; Ahmed B Hashim; Rebecca C Harris; Arina Zanuzdana; Gabriel Agboado; Elizabeth Orton; Laura Béchard-Evans; Gemma Morgan; Charlotte Stevenson; Rachel Weston; Mitsuru Mukaigawara; Joanne Enstone; Glenda Augustine; Mobasher Butt; Sophie Kim; Richard Puleston; Girija Dabke; Robert Howard; Julie O'Boyle; Mary O'Brien; Lauren Ahyow; Helene Denness; Siobhan Farmer; Jose Figureroa; Paul Fisher; Felix Greaves; Munib Haroon; Sophie Haroon; Caroline Hird; Rachel Isba; David A Ishola; Marko Kerac; Vivienne Parish; Jonathan Roberts; Julia Rosser; Sarah Theaker; Dean Wallace; Neil Wigglesworth; Liz Lingard; Yana Vinogradova; Hiroshi Horiuchi; Javier Peñalver; Jonathan S Nguyen-Van-Tam
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

5.  Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis.

Authors:  Julius Atashili; Linda Kalilani; Adaora A Adimora
Journal:  BMC Infect Dis       Date:  2006-09-11       Impact factor: 3.090

Review 6.  Influenza vaccination in HIV-positive subjects: latest evidence and future perspective.

Authors:  A Ceravolo; A Orsi; V Parodi; F Ansaldi
Journal:  J Prev Med Hyg       Date:  2013-03

7.  Immune activation and viral replication after vaccination with an influenza A H1N1 2009 vaccine in HIV-infected children receiving antiretroviral therapy.

Authors:  Nattawat Onlamoon; Petai Unpol; Michittra Boonchan; Kasama Sukapirom; Orasri Wittawatmongkol; Kulkanya Chokephaibulkit; Palanee Ammaranond; Kovit Pattanapanyasat
Journal:  Dis Markers       Date:  2013-09-05       Impact factor: 3.434

8.  Vaccinia and other viruses with available vaccines show marked homology with the HIV-1 envelope glycoprotein: the prospect of using existing vaccines to stem the AIDS pandemic.

Authors:  C J Chris Carter
Journal:  Immunopharmacol Immunotoxicol       Date:  2011-08-19       Impact factor: 3.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.